Critical congenital heart disease screening

Area of Science:

• Neonatal care
• Pediatric cardiology
• Public health screening

Background:

• Critical congenital heart disease (CCHD) presents a significant threat to infant survival, often necessitating immediate surgical intervention.
• Historically, routine screening for CCHD was lacking, leading to delayed diagnoses and poorer health outcomes.
• Recent advancements have introduced pulse oximetry as a recommended screening tool for newborns.

Purpose of the Study:

• To highlight the importance of early diagnosis of CCHD in newborns.
• To discuss the role of pulse oximetry screening in identifying CCHD.
• To inform about the current screening protocols and parental consent considerations.

Main Methods:

• Review of current screening protocols for CCHD in neonates.
• Emphasis on the utility of pulse oximetry for CCHD detection.
• Discussion of the implications of positive screening results, including echocardiogram referrals.

Main Results:

• Pulse oximetry screening is increasingly adopted as part of uniform newborn screening panels.
• A positive pulse oximetry result necessitates further evaluation with an echocardiogram.
• Newborn screening generally does not require parental consent, though exemptions exist.

Conclusions:

• Early detection of CCHD through pulse oximetry screening can significantly improve infant outcomes.
• Pulse oximetry screening represents a crucial advancement in neonatal cardiac care.
• Understanding screening protocols and exemption policies is important for healthcare providers and parents.